Fetal EchoScan vs Eko Low Ejection Fraction Tool (ELEFT)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Fetal EchoScan, is designed for prenatal detection of congenital heart defects using AI-powered ultrasound, focusing on fetal cardiac assessments. In contrast, Tool B, Eko Low Ejection Fraction Tool (ELEFT), aids in the early identification of low ejection fraction, a key indicator of heart failure in adults, by integrating AI with digital stethoscopes. While both are cardiology AI tools, they target different patient populations and distinct cardiac conditions using different diagnostic modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Fetal EchoScan is an AI-powered ultrasound screening software designed to assist clinicians in the prenatal detection of congenital heart defects during ultrasound examinations. The Eko Low Ejection Fraction Tool (ELEFT) is an AI algorithm that aids in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Fetal EchoScan is a cloud-based software-only device that integrates with existing ultrasound workflows and machines. The Eko Low Ejection Fraction Tool requires integration with FDA-cleared Eko digital stethoscopes.
Fetal EchoScan offers seamless integration with existing ultrasound machines and reporting solutions, providing real-time AI analysis and alerts on a cart-side tablet display. Eko Low Ejection Fraction Tool integrates with Eko digital stethoscopes to analyze ECG and heart sound recordings during routine physical exams, providing results in approximately 15 seconds.
Fetal EchoScan utilizes AI to analyze prenatal ultrasound examinations for congenital heart defects. The Eko Low Ejection Fraction Tool analyzes ECG and heart sound recordings captured by Eko digital stethoscopes to detect low ejection fraction.
Fetal EchoScan is designed for prenatal patients, specifically pregnant women aged 18 or older undergoing second-trimester anatomic ultrasound exams, assisting in the screening for congenital heart defects in fetuses. The Eko Low Ejection Fraction Tool is intended for use on adult patients at risk for heart failure, aiding in the early identification of low ejection fraction.
Fetal EchoScan provides AI-driven support, automated CHD detection, real-time guidance, ensures exam completeness and standardization, and aims to reduce false-negative and false-positive errors. The Eko Low Ejection Fraction Tool offers AI-powered low ejection fraction detection, aids in early identification of heart failure risk, and delivers results quickly as a non-invasive screening tool.
More Comparisons
Backers
Who funded each tool's parent company.